RAPPRapport Therapeutics, Inc.

$52.44

Who owns RAPP

147 institutions reported holding RAPP for 2026Q1, together 111% of the company, more than the 142 a quarter earlier.

147

Institutions reporting a position · as of 2026Q1 · up from 142 the quarter before

Shares held by institutions
52.5M

Shares held by institutions · 111% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.64B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
23 / 25

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
8
New positions
23
Positions exited
25
Added to
50
Reduced
34
Institutional ownership by quarter, 2024Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q114752.5M$1.64B
2025Q414251.1M$1.55B
2025Q312249.3M$1.46B
2025Q28138.5M$438M
2025Q17638.1M$382M
2024Q46936.6M$649M
2024Q35428.4M$582M
2024Q23425.6M$593M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC7.2Mn/a$224M
TRV GP V, LLC7.1Mn/a$223M
ARCH Venture Management, LLC3.7Mn/a$117M
Capital International Investors3.1Mn/a$97M
Cormorant Asset Management, LP3.0Mn/a$93M
GOLDMAN SACHS GROUP INC2.9Mn/a$92M
BlackRock Inc.2.5Mn/a$78M
Sofinnova Investments, Inc.1.9Mn/a$60M
VANGUARD GROUP INC1.9Mn/a$59M
JOHNSON & JOHNSON1.8Mn/a$56M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…